title: Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix.
abstract: BACKGROUND
  This study was performed to identify pathologic and clinical features that best predict disease free survival of patients with early stage small cell carcinoma of the cervix treated by radical hysterectomy.
  
  
  METHODS
  Three hundreds and seventy patients with cervical carcinoma were analyzed retrospectively to define those variable that best predict disease free survival (DFS). Variables included age, weight, race, marital status, economic status, tumor size, depth of invasion (DI), lymph-vascular space involvement (LVSI), cell type, tumor grade, lymph node metastasis (LNM), and total number of lymph nodes removed. Patients with lymph node metastasis, parametrial involvement, and positive or close surgical margins were offered postoperative radiation.
  
  
  RESULTS
  Twelve patients were found to have small cell carcinoma (3.2%). One patient had microinvasive carcinoma of the cervix (MIC) as defined by the Society of Gynecologic Oncologists with a depth of invasion of 3 mm or less and no lymph-vascular space invasion, and has been reported previously. A detailed analysis of the other patients with nonsmall cell carcinoma is presented separately. Five patients achieved a DFS of at least 5 years, whereas 7 patients died with disease. Excluding the patient with MIC, the 5-year DFS rate was 36.4%.
  
  
  CONCLUSIONS
  Relative to other cell types, small cell carcinomas of the cervix is an aggressive neoplasm with a higher rate of LVSI and LNM despite smaller DI and tumor size. These data suggest that multimodality therapy, combining radical surgery and radiation with cytotoxic chemotherapy, may provide these patients with the best chance for cure.
authors.affiliation: Division of Gynecologic Oncology, University of Miami School of Medicine, Florida 33136, USA.
authors.forename: B U
authors.initials: BU
authors.lastname: Sevin
authors.forename: M W
authors.initials: MW
authors.lastname: Method
authors.forename: M
authors.initials: M
authors.lastname: Nadji
authors.forename: Y
authors.initials: Y
authors.lastname: Lu
authors.forename: H A
authors.initials: HA
authors.lastname: Averette
mesh_terms: D000328:Adult; D000368:Aged; D018288:Carcinoma, Small Cell / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000601:surgery*